Status:

ACTIVE_NOT_RECRUITING

Reproducibility of Minimally Invasive Surgery for Grade III Hemorrhoids

Lead Sponsor:

Hospital Son Llatzer

Collaborating Sponsors:

Fundació d'investigació Sanitària de les Illes Balears

Conditions:

Hemorrhoidectomy

Minimal Invasive Surgery

Eligibility:

All Genders

18+ years

Brief Summary

Hemorrhoids are vascular-elastic structures of the anal canal that contribute to continence. Their enlargement and descent lead to symptoms such as rectal bleeding and the sensation of anal swelling, ...

Eligibility Criteria

Inclusion

  • Age over 18 years
  • Grade III hemorrhoids
  • BMI below 30
  • Indication for OEH surgery
  • Signed written informed consent

Exclusion

  • Acute hemorrhoidal disease (thrombosis)
  • Previous hemorrhoid surgery
  • Coexistence of anal fissure
  • Coexistence of perianal fistula
  • Coexistence of rectal or anal prolapse
  • Active inflammatory bowel disease
  • Active anal or colorectal cancer
  • Language barrier or difficulty in oral and/or written comprehension

Key Trial Info

Start Date :

August 12 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 31 2026

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT07171294

Start Date

August 12 2025

End Date

January 31 2026

Last Update

December 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Son Llatzer

Palma, Spain, 07190

Reproducibility of Minimally Invasive Surgery for Grade III Hemorrhoids | DecenTrialz